• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种高致病性人类冠状病毒(中东呼吸综合征冠状病毒、严重急性呼吸综合征冠状病毒和新型冠状病毒)的比较病理学、分子发病机制、免疫学特征和遗传特征。

Comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of three highly pathogenic human coronaviruses (MERS-CoV, SARS-CoV, and SARS-CoV-2).

机构信息

Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

出版信息

Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7162-7184. doi: 10.26355/eurrev_202111_27270.

DOI:10.26355/eurrev_202111_27270
PMID:34859882
Abstract

The last two decades have witnessed the emergence of three deadly coronaviruses (CoVs) in humans: severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There are still no reliable and efficient therapeutics to manage the devastating consequences of these CoVs. Of these, SARS-CoV-2, the cause of the currently ongoing coronavirus disease 2019 (COVID-19) pandemic, has posed great global health concerns. The COVID-19 pandemic has resulted in an unprecedented crisis with devastating socio-economic and health impacts worldwide. This highlights the fact that CoVs continue to evolve and have the genetic flexibility to become highly pathogenic in humans and other mammals. SARS-CoV-2 carries a high genetic homology to the previously identified CoV (SARS-CoV), and the immunological and pathogenic characteristics of SARS-CoV-2, SARS-CoV, and MERS contain key similarities and differences that can guide therapy and management. This review presents salient and updated information on comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of SARS-CoV, MERS-CoV, and SARS-CoV-2; this can help in the design of more effective vaccines and therapeutics for countering these pathogenic CoVs.

摘要

过去的二十年见证了三种致命的人类冠状病毒(CoV)的出现:严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)。目前仍然没有可靠和有效的治疗方法来应对这些 CoV 造成的毁灭性后果。其中,SARS-CoV-2 是导致目前正在发生的 2019 年冠状病毒病(COVID-19)大流行的原因,引起了极大的全球健康关注。COVID-19 大流行导致了一场前所未有的危机,给全球的社会经济和健康带来了毁灭性的影响。这突显出 CoV 仍在不断进化,并具有在人类和其他哺乳动物中高度致病的遗传灵活性。SARS-CoV-2 与之前鉴定的 CoV(SARS-CoV)具有很高的遗传同源性,SARS-CoV-2、SARS-CoV 和 MERS-CoV 的免疫和发病特点包含关键的相似性和差异,这可以指导治疗和管理。本综述介绍了 SARS-CoV、MERS-CoV 和 SARS-CoV-2 的比较病理学、分子发病机制、免疫学特征和遗传特征的最新信息;这有助于设计更有效的疫苗和治疗方法来对抗这些致病的 CoV。

相似文献

1
Comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of three highly pathogenic human coronaviruses (MERS-CoV, SARS-CoV, and SARS-CoV-2).三种高致病性人类冠状病毒(中东呼吸综合征冠状病毒、严重急性呼吸综合征冠状病毒和新型冠状病毒)的比较病理学、分子发病机制、免疫学特征和遗传特征。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7162-7184. doi: 10.26355/eurrev_202111_27270.
2
From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.从 SARS 和 MERS CoVs 到 SARS-CoV-2:病毒结构和非结构基因中更偏向于使用密码子。
J Med Virol. 2020 Jun;92(6):660-666. doi: 10.1002/jmv.25754. Epub 2020 Mar 16.
3
From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses.从 SARS 和 MERS 到 COVID-19:三种高致病性人冠状病毒引起的严重急性呼吸道感染的简要总结和比较。
Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w.
4
Genome-Wide B Cell, CD4, and CD8 T Cell Epitopes That Are Highly Conserved between Human and Animal Coronaviruses, Identified from SARS-CoV-2 as Targets for Preemptive Pan-Coronavirus Vaccines.从 SARS-CoV-2 中鉴定出高度保守的人类和动物冠状病毒的全基因组 B 细胞、CD4 和 CD8 T 细胞表位,作为预防性泛冠状病毒疫苗的靶点。
J Immunol. 2021 Jun 1;206(11):2566-2582. doi: 10.4049/jimmunol.2001438. Epub 2021 Apr 28.
5
The lethal internal face of the coronaviruses: Kidney tropism of the SARS, MERS, and COVID19 viruses.冠状病毒致命的内在一面:SARS、MERS 和 COVID19 病毒对肾脏的趋向性。
IUBMB Life. 2021 Aug;73(8):1005-1015. doi: 10.1002/iub.2516. Epub 2021 Jun 30.
6
Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.新兴人类冠状病毒感染(SARS、MERS 和 COVID-19):它们将把我们带向何方。
Int Rev Immunol. 2021;40(1-2):5-53. doi: 10.1080/08830185.2020.1800688. Epub 2020 Aug 3.
7
The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus.SARS-CoV-2 传播的独特特征:与 SARS-CoV、MERS-CoV 和 2009 年 H1N1 大流行性流感病毒的比较。
Rev Med Virol. 2021 Mar;31(2):e2171. doi: 10.1002/rmv.2171. Epub 2020 Sep 18.
8
From SARS to MERS, Thrusting Coronaviruses into the Spotlight.从 SARS 到 MERS,冠状病毒备受瞩目。
Viruses. 2019 Jan 14;11(1):59. doi: 10.3390/v11010059.
9
Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.冠状病毒:关于其复制与发病机制的最新综述
Methods Mol Biol. 2020;2203:1-29. doi: 10.1007/978-1-0716-0900-2_1.
10
Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.基于与病毒蛋白酶分子相互作用的抗 SARS-CoV 药物的设计与评估。
Molecules. 2020 Aug 27;25(17):3920. doi: 10.3390/molecules25173920.

引用本文的文献

1
Middle East Respiratory Syndrome Coronavirus Could be a Priority Pathogen to Cause Public Health Emergency: Noticeable Features and Counteractive Measures.中东呼吸综合征冠状病毒可能是引发突发公共卫生事件的重点病原体:显著特征与应对措施
Environ Health Insights. 2024 Aug 15;18:11786302241271545. doi: 10.1177/11786302241271545. eCollection 2024.
2
Editorial: and models for research in pathology.社论:以及病理学研究模型。
Pathol Oncol Res. 2023 Apr 4;29:1611196. doi: 10.3389/pore.2023.1611196. eCollection 2023.
3
Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs.
比格犬对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和中东呼吸综合征冠状病毒(MERS-CoV)的易感性。
Animals (Basel). 2023 Feb 10;13(4):624. doi: 10.3390/ani13040624.
4
Modifiable contributing factors to COVID-19: A comprehensive review.可改变的 COVID-19 致病因素:全面综述。
Food Chem Toxicol. 2023 Jan;171:113511. doi: 10.1016/j.fct.2022.113511. Epub 2022 Nov 28.
5
De novo natural anti-M alloantibody emergence in severe Coronavirus Disease 2019.新型冠状病毒病 2019 中严重病例天然抗-M 同种异体抗体的产生。
J Infect Public Health. 2022 Dec;15(12):1455-1458. doi: 10.1016/j.jiph.2022.10.025. Epub 2022 Nov 2.
6
Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses.植物分子制药与植物衍生化合物用于研发抗冠状病毒疫苗和治疗药物
Vaccines (Basel). 2022 Oct 26;10(11):1805. doi: 10.3390/vaccines10111805.
7
MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.微小 RNA 在开发针对 COVID-19 的潜在治疗靶点中的作用:叙事性综述。
J Infect Public Health. 2022 Jul;15(7):788-799. doi: 10.1016/j.jiph.2022.06.012. Epub 2022 Jun 21.
8
Coronavirus disease 2019 presenting as psychosis: a case report.以精神病为表现的2019冠状病毒病:一例报告
J Med Case Rep. 2022 Apr 22;16(1):171. doi: 10.1186/s13256-022-03349-z.
9
Acute Pericarditis Secondary to COVID-19 Infection.新型冠状病毒肺炎感染继发急性心包炎
Cureus. 2021 Dec 26;13(12):e20709. doi: 10.7759/cureus.20709. eCollection 2021 Dec.